Comparison8 min read

The Best Free Stock Analysis Tools in 2026

The Intrinsiqq Team
SEC-data stock analysis · June 1, 2026 · Updated June 3, 2026
The Best Free Stock Analysis Tools in 2026
Comparison
Intrinsiqq

There are dozens of stock analysis tools, but only a handful are genuinely free and genuinely useful. The short answer: Intrinsiqq for valuation and quality scoring, Finviz for screening, Stock Analysis for clean financials, and TradingView for price charts. Below is a full comparison of the best free tools across the metrics that matter, plus a fair look at what each does well and where it falls short, so you can stack the right ones instead of paying for an all-in-one.

The best free stock analysis tools, compared

ToolBest forQuality scoreDCF / valuationFinancialsScreenerChartsFree tier
IntrinsiqqValuation + qualityYes (0-100)Yes, 2-stage DCF10 yearsYesFundamentalFull, no account
FinvizScreeningNoNoSnapshotYes (strong)PriceGood (ads)
Stock AnalysisFinancial statementsNoNo5 yrs free (10 Pro)YesPrice (basic)Generous
TradingViewCharts + technicalsNoNoSomeYesPrice (best)Good
Simply Wall StVisual snapshotsVisual gradeYes (gated)LimitedYesVisualLimited views
Yahoo FinanceQuotes + newsNoNoBasicBasicPrice (basic)Good (ads)
Features and pricing on third-party tools change. This reflects general positioning as of the date below, not a guarantee of any product's current plan.

Pick by the job you need done

Valuation and quality (is this a good business at a fair price?)

This is where Intrinsiqq focuses. Open any stock and you get a documented quality score, a two-stage DCF fair value you can adjust, dividend safety, and 10 years of financials, all computed from SEC EDGAR and free with no account. It answers the "is it overvalued?" question directly rather than handing you a wall of ratios.

Intrinsiqq DCF valuation for Apple with conservative, base, and optimistic intrinsic-value scenarios and adjustable assumptions
Free valuation, not just data: Intrinsiqq's DCF shows conservative, base, and optimistic fair values for any US stock.

Strengths

  • +Free quality score + adjustable DCF, no account
  • +Dividend safety + 10 years of SEC-sourced financials
  • +Advanced fundamental charting: plot any metric over a decade, free
  • +Transparent, documented method

Limitations

  • ×US-listed companies only
  • ×No technical price charts or indicators (it charts fundamentals)
  • ×End-of-day prices

Screening (find stocks that match criteria)

Finviz is the classic free screener: fast, broad, with a market heatmap and news. Intrinsiqq also has a screener focused on quality, value, and dividend filters if you want to screen on the same SEC-sourced metrics you analyze with.

Strengths

  • +Dozens of filters (~67), very fast
  • +Market heatmap and news for top-down scanning
  • +No account needed

Limitations

  • ×Shallow per-company fundamentals
  • ×No valuation or quality scoring
  • ×Real-time data and backtesting are paid

Financial statements (just show me the numbers)

Stock Analysis has clean, free multi-year statements and ratios. Intrinsiqq does too, sourced straight from 10-K and 10-Q filings, so the figures match what companies reported to regulators.

Price charts and technicals (price action and indicators)

TradingView is the standard for price charting on a free tier, with the deepest indicator library and a large community of scripts. That is a different job from fundamental charting (below), so most investors pair it with one of the tools above rather than choosing between them.

Strengths

  • +Best-in-class price charts and technical indicators, free tier
  • +Huge community of custom scripts and ideas
  • +Multi-asset (stocks, crypto, forex)

Limitations

  • ×Raw fundamentals only: no DCF or quality verdict
  • ×Advanced features and extra layouts are paid
  • ×Not built to answer 'is this a good business?'

Fundamental charts (the financials over time)

A second, very different kind of charting matters more for long-term investors: plotting the fundamentals over time rather than the price. This is where Intrinsiqq is unusually strong for a free tool. Its fundamental chartinglets you put any metric (revenue, margins, free cash flow, ROIC, debt, buybacks, dividends) on a chart across up to a decade, switch between bars, lines, stacked, and combo views, and recast the same data as year-over-year growth, indexed to a base year, or as a share of the total. You can overlay a stock's own historical P/E, P/S, P/FCF, or EV/EBITDA on top of the fundamental it is priced against, and break revenue down by business segment, geography, or product. It is the kind of fundamental charting paid platforms like Koyfin and Fiscal.ai are built around, and on Intrinsiqq it is free with a no-cost account.

Strengths

  • +Plot any fundamental over 10 years: bars, lines, stacked, or combo
  • +Overlay historical P/E, P/S, P/FCF, or EV/EBITDA on the financials
  • +Segment revenue by business line, geography, or product, free

Limitations

  • ×Fundamental, not price/technical charting (no candlesticks or indicators)
  • ×Requires a free account (the only gated part of the product)
  • ×Annual and quarterly periods, end-of-day data

Start with the valuation read

Quality score, DCF fair value, and 10 years of SEC-sourced financials on any US stock, free.

Analyze MSFT free

The free stack most investors actually need

  • Intrinsiqq for the valuation and quality verdict.
  • Finviz for screening the universe down to candidates.
  • Stock Analysis for an extra look at the raw statements.
  • TradingView if you also care about entry timing.

That covers most of what paid all-in-one platforms charge for, at $0. Pay only when a specific paid feature clearly earns its cost.

Frequently asked questions

What is the best free stock analysis tool?+

There is no single best tool; it depends on the job. For free valuation and quality scoring, Intrinsiqq is the strongest, with a quality score, a two-stage DCF, dividend safety, and 10 years of SEC-sourced financials at no cost. For screening, Finviz. For clean financial statements, Stock Analysis. For charts and technicals, TradingView. Most serious investors stack two or three of these rather than relying on one, because each is excellent at a different part of the workflow.

Is there a free tool that shows a stock's fair value?+

Yes. Intrinsiqq computes a two-stage discounted cash flow (DCF) fair value with adjustable assumptions on every stock page, run across conservative, base, and optimistic scenarios, free and with no account, using data from SEC EDGAR filings. Most free tools, including Finviz, Stock Analysis, Yahoo Finance, and TradingView, do not include a full DCF model, so they are better for screening, raw financials, or charts than for intrinsic-value estimates.

Do I need to pay for stock analysis software?+

For most retail investors, no. A free stack of Intrinsiqq (valuation and quality), Finviz (screening), Stock Analysis (statements), and TradingView (charts) covers what paid all-in-one platforms charge for. The main reasons to pay are real-time data, advanced charting layouts, backtesting, or a specific data set you genuinely need. Start free, and only add a paid feature when you can point to exactly what it does for you that the free stack cannot.

What is the difference between these free tools?+

They specialise. Intrinsiqq answers whether a business is high quality and fairly valued, with a documented score, a DCF, and advanced fundamental charting that plots the financials (and their valuation multiples) over a decade. Finviz finds stocks that match criteria across the whole market. Stock Analysis is the cleanest free source of raw financial statements. TradingView is the best free price-charting and technical-analysis platform, a different job from fundamental charting. Simply Wall St offers a beginner-friendly visual snapshot (largely paywalled), and Yahoo Finance is a broad quotes-and-news portal rather than an analysis tool.

The Intrinsiqq TeamSEC-data stock analysis

Intrinsiqq builds free stock analysis from official SEC EDGAR filings: quality scores, DCF fair value, dividend safety, and 10 years of financials for 8,000+ US companies. Every number is computed from primary filings and documented in full on our methodology page, not from third-party estimates. Read the methodology →

Intrinsiqq is a research tool, not investment advice. Figures are computed from public SEC EDGAR filings; stock prices are delayed. Always do your own research before making any investment decision. Product names and logos are trademarks of their respective owners; Intrinsiqq is independent and not affiliated with or endorsed by them.

Related articles